Provides a bit of an idea of how the stock might rerate if the trial results are positive as hoped.
Having said that, I maintain that the company at its current stage (pre stage 2 data) is significantly undervalued at its current market cap. So really expecting the coming re-rate to incorporate both a portion for catching up to where it should be now, plus (pending success in coming trial results) a further sifnicant rerate for increased likelihood of making it to market
Buyers to sellers ratio of 8:1
- Forums
- ASX - By Stock
- DLM
- FTT relative valuation suggests fair value of around 20c
FTT relative valuation suggests fair value of around 20c, page-25
Featured News
Add DLM (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $7.227M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
DLM (ASX) Chart |
Day chart unavailable